India, May 30 -- Women who eat a lot of healthy carbs, such as fruits, vegetables, whole grains, and beans, are more likely to stay healthy as they get older, according to a recent study by researcher... Read More
India, May 30 -- Japan's housing starts decreased sharply in April after a surge in the previous month, data from the Ministry of Land, Infrastructure, Transport, and Tourism showed on Friday. Housin... Read More
India, May 30 -- Data infrastructure company NetApp Inc. (NTAP) on Thursday revealed outlook for the first quarter and fiscal 2026, expecting year-over-year growth in the year, after reporting higher ... Read More
India, May 30 -- National Grid plc (NGG) has officially completed the sale of its National Grid Renewables division to Brookfield Asset Management, along with its institutional partners, including Bro... Read More
India, May 30 -- Elastic N.V. (ESTC) shares fell 12.80 percent to $80.25, down $11.78 on Friday, a possible reaction to the company's fourth-quarter earnings report, announced yesterday which showed s... Read More
India, May 30 -- Global Interactive Technologies, Inc. (GITS) shares skyrocketed 119.45 percent to $2.11 on, gaining $1.14 in intraday trading Friday, even though no news or filings have been released... Read More
India, May 30 -- Inflation and retail sales from Germany and private sector credit from the euro area are the top economic news due on Friday. At 2.00 am ET, Destatis is scheduled to issue Germany's ... Read More
India, May 30 -- Regeneron Pharmaceuticals, Inc. (REGN) shares plummeted 19.06 percent to $489.99, down $115.41 on Friday, after announcing mixed results from its Phase 3 trials evaluating itepekimab ... Read More
India, May 30 -- Australia retail sales declined for the first time in four months in April, data from the Australian Bureau of Statistics showed on Friday. Retail sales fell 0.1 percent on a monthly... Read More
India, May 30 -- Regeneron Pharmaceuticals Inc. (REGN) and French drug major Sanofi S.A. (SNYNF,SNY) announced Friday that Itepekimab met the primary endpoint in one of two trials of chronic obstructi... Read More